Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes - The Hong Kong diabetes registry

Diabetes/Metabolism Research and Reviews

Volumn 24, Issue 3, 2008, Pages 238-246

  So, Wing Yee ^a   Yang, Xilin ^a   Ma, Ronald C W ^a   Kong, Alice P S ^a   Lam, Christopher W K ^a   Ho, Chung Shun ^a   Cockram, Clive S ^a   Ko, Gary T C ^a   Chow, Chun Chung ^a   Wong, Vivian ^b   Tong, Peter C Y ^a   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

All cause mortality; Chinese; Hong Kong; Non linearity; Prognosis; Risk factors; Type 2 diabetes; V shape

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CAUSE OF DEATH; CHINESE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HONG KONG; HUMAN; KIDNEY DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; UROGENITAL TRACT DISEASE;

BODY SIZE; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 40749137742     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.792     Document Type: Article

References (36)

1. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005; 28: 2130-2135.
2. Liu J, Sempos C, Donahue RP, et al. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005; 28: 1916-1921.
3. Manson J, Colditz G, Stampfer M, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141-1147.
4. Almdal T, Scharling H, Jensen JS, et al. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164: 1422-1426.
5. Wu AY, Kong NC, de Leon FA, et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005; 48: 17-26.
6. Lipscombe LL, Goodwin PJ, Zinman B, et al. Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 2006; 98: 349-356.
7. Seow A, Yuan JM, Koh WP, et al. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst 2006; 98: 135-138.
8. Bertoni AG, Kirk JK, Goff DC Jr, et al. Excess mortality related to diabetes mellitus in elderly Medicare beneficiaries. Ann Epidemiol 2004; 14: 362-367.
9. Bertoni AG, Krop JS, Anderson GF, et al. Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care 2002; 25: 471-475.
10. Yuan JM, Ross RK, Gao YT, et al. Body weight and mortality: a prospective evaluation in a cohort of middle-aged men in Shanghai, China. Int J Epidemiol 1998; 27: 824-832.
11. Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases-report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci 2002; 15: 245-252.
12. Gu D, He J, Duan X, et al. Body weight and mortality among men and women in China. JAMA 2006; 295: 776-783.
13. Perova NV, Oganov RG, Williams DH, et al. Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men. Ann Epidemiol 1995; 5: 179-185.
14. Piwernetz K, Home PD, Snorgaard O, et al. For the DiabCare monitoring group of the St. Vincent declaration steering committee. Monitoring the targets of the St. Vincent declaration and the implementation of quality management in diabetes care: the DiabCare initiative. Diabet Med 1993; 10: 371-377.
15. So WY, Ozaki R, Chan NN, et al. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension 2004; 44: 294-299.
16. Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 2004; 27: 216-222.
17. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944.
18. So WY, Kong AP, Ma RC, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006; 29: 2046-2052.
19. Yang X, So WY, Kong AP, et al. End-stage renal disease risk equations for Hong Kong Chinese Type 2 diabetic patients: Hong Kong Diabetes Registry. Diabetologia 2006; 49: 2299-2308.
20. Harrell F. Regression Modelling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. Spinger-Varlag New York, Inc: New York, 2001.
21. Lin DY, Wei LJ, Ying Z. Checking the cox model with cumulative sums of martingale-based residuals. Biometrika 1993; 80: 557-572.
22. Song YM, Ha M, Sung J. Body mass index and mortality in middle-aged Korean women. Ann Epidemiol 2007; 17: 556-563.
23. Breeze E, Clarke R, Shipley MJ, et al. Cause-specific mortality in old age in relation to body mass index in middle age and in old age: follow-up of the Whitehall cohort of male civil servants. Int J Epidemiol 2006; 35: 169-178.
24. Yokoyama H, Okudaira M, Otani T, et al. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis. Diabetes Care 1998; 21: 1080-1085.
25. Chan JC, Wat NM, So WY, et al. Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study. Diabetes Care 2004; 27: 874-879.
26. Wilson PW, Abbott RD, Gastelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988; 8: 737-741.
27. Gordon T, Kannel WB, Castelli WP, et al. Lipoproteins, cardiovascular disease, and death. The Framingham Study. Arch Intern Med 1981; 141: 1128-1131.
28. Chan JC, Ko GT, Leung DH, et al. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Kidney Int 2000; 57: 590-600,
29. Shearer GC, Newman JW, Hammock BD, et al. Graded effects of proteinuria on HDL structure in nephrotic rats. J Am Soc Nephrol 2005; 16: 1309-1319.
30. Batista MC, Welty FK, Diffenderfer MR, et al. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome. Metabolism 2004; 53: 1255-1261.
31. Stehouwer CD, Henry RM, Dekker JM, et al. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction-the Hoorn Study. Kidney Int Suppl 2004; (92): S42-S44.
32. Chan WB, Chan NN, Lai CW, et al. Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency. Kidney Int 2006; 70(4): 711-716.
33. Nag S, Bilous R, Kelly W, et al. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study. Diabet Med 2007; 24: 10-17.
34. Bruno G, Merletti F, Bargero G, et al. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia 2007; 50: 941-948.
35. Schooling CM, Lam TH, Li ZB, et al. Obesity, physical activity, and mortality in a prospective Chinese elderly cohort. Arch Intern Med 2006; 166: 1498-1504.
36. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.